Deep Origin
Deep Origin is a biotechnology company that help's scientists solve disease and extend healthspan by building tools that simplify R&D, simulate biology, and untangle the complexity of life. Streamline computational analysis today. Simulate biology tomorrow.
Leave No Development Candidate Behind 90% of drugs fail in clinical development. Most of that failure happens because preclinical models are poor predictors of what happens in humans. We are building the models that close that gap. Want to run our tools yourself? Explore the platform → 100+ scientists in biology, chemistry & physics $50M + $32M capital raised · ARPA-H contract 2 / 40 partnership slots filled CD73 program · 159 compounds, 30% hit rate Our team has built and partnered at Drug Discovery Partnerships 9 in 10 drugs entering clinical trials never get approved Decades of…
saved by
related reading
- Convoke | Biopharma's Operating Systemconvoke.bio
- Manifold Bio | Tissue-targeted medicines, designed in vivomanifold.bio
- Reimagining Drug Discovery Process with AI - Isomorphic Labsisomorphiclabs.com
- principia labsprincipialabs.org
- Curie.Biocurie.bio
- OCTO - Noetiknoetik.ai
- Democratizing frontier AI R&D to accelerate science and technologymirendil.com
- Deep Checks: Meet the best deeptech seed investorsdeepchecks.vc
- Where are all the trillion dollar biotechs?ladanuzhna.xyz
- Solutions | PolyModels Hubpolymodelshub.com
- Kekulaikekulai.com
- Rebuild Biotech for the AI Era | Benchlingbenchling.com